Valley View Healthcare & Rehab | |
510 East Cedar Street, Houston, Minnesota 55943 | |
(507) 896-3125 | |
Name | Valley View Healthcare & Rehab |
---|---|
Location | 510 East Cedar Street, Houston, Minnesota |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 45 |
Occupancy Rate | 78.89% |
Medicare ID (CCN) | 245566 |
Legal Business Name | Valley View Nursing Home Of Houston, Inc. |
Ownership Type | Non Profit - Corporation |
NPI Number | 1568465607 |
Organization Name | VALLEY VIEW NURSING HOME OF HOUSTON, INC. |
Address | 510 E Cedar St, Houston, MN 55943 |
Phone Number | 507-896-3125 |
News Archive
Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China, announced today that it has entered R-Bambuterol Clinical Trial I on-schedule and is on-track to complete in six months. The studies will evaluate the safety and tolerability of the new drug as well as the biological activity by measuring responses in healthy volunteers.
Scientists have enlisted the exotic properties of graphene, a one-atom-thick layer of carbon, to function like the film of an incredibly sensitive camera system in visually mapping tiny electric fields in a liquid.
Scientists at Queen Mary University of London (QMUL) have identified differences in the proteins present in young and old tendons, in new research that could guide the development of treatments to stop tissue breakdown from occurring.
Taking antibiotics weekly for one year does not reduce the risk of a heart attack or other cardiac event for patients with stable coronary artery disease, according to a study funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health. It is published in the April 21, 2005, edition of the New England Journal of Medicine.
› Verified 7 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China, announced today that it has entered R-Bambuterol Clinical Trial I on-schedule and is on-track to complete in six months. The studies will evaluate the safety and tolerability of the new drug as well as the biological activity by measuring responses in healthy volunteers.
Scientists have enlisted the exotic properties of graphene, a one-atom-thick layer of carbon, to function like the film of an incredibly sensitive camera system in visually mapping tiny electric fields in a liquid.
Scientists at Queen Mary University of London (QMUL) have identified differences in the proteins present in young and old tendons, in new research that could guide the development of treatments to stop tissue breakdown from occurring.
Taking antibiotics weekly for one year does not reduce the risk of a heart attack or other cardiac event for patients with stable coronary artery disease, according to a study funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health. It is published in the April 21, 2005, edition of the New England Journal of Medicine.
› Verified 7 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $650 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 12.82 | 14.46 |
Percentage of long-stay residents who lose too much weight | 4.31 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 55.38 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.8 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 3.08 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 3.91 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 6.77 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 7.09 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 96.25 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 30.19 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 13.33 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 8 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.31 | 95.98 |
Percentage of short-stay residents who made improvements in function | 70.03 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 92.13 | 82.93 |
News Archive
Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China, announced today that it has entered R-Bambuterol Clinical Trial I on-schedule and is on-track to complete in six months. The studies will evaluate the safety and tolerability of the new drug as well as the biological activity by measuring responses in healthy volunteers.
Scientists have enlisted the exotic properties of graphene, a one-atom-thick layer of carbon, to function like the film of an incredibly sensitive camera system in visually mapping tiny electric fields in a liquid.
Scientists at Queen Mary University of London (QMUL) have identified differences in the proteins present in young and old tendons, in new research that could guide the development of treatments to stop tissue breakdown from occurring.
Taking antibiotics weekly for one year does not reduce the risk of a heart attack or other cardiac event for patients with stable coronary artery disease, according to a study funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health. It is published in the April 21, 2005, edition of the New England Journal of Medicine.
› Verified 7 days ago
Valley View Healthcare & Rehab Location: 510 East Cedar Street, Houston, Minnesota 55943 Phone: (507) 896-3125 |